Receiving-site gap assessmentQuality agreement reviewFirst-lot release records
Home / Sending-Site and Receiving-Site Gap Assessment

Sending-Site and Receiving-Site Gap Assessment

Build a gap record that distinguishes missing evidence, mismatched scope and unresolved responsibilities.

Which differences affect the proposed scope?

Start with the list of responsibilities the buyer expects to move. Ask both parties where each activity currently sits and what evidence the proposed receiving team can supply. A missing document, a contractual restriction and a genuine capability gap call for different decisions. WHO’s pharmaceutical transfer guidance discusses gap analysis and due diligence. A purchasing record can translate that idea into named issues with owners and a decision date.

WHO (2022) · Technology transfer in pharmaceutical manufacturing, TRS 1044 Annex 4

A circular feed bowl and guide rails are visible beside a row of containers.
Container feed and guide railsThe overview distinguishes container handling from the separate decision to release a particular lot.
Image creditsCompany footage
Horizontal shelves are visible through a round observation window in a piece of enclosed equipment.
Chamber observation windowA recorded equipment view gives context when reviewing which facility a transfer dossier describes.
Image creditsCompany footage

What is a meaningful response to a gap?

Ask for a specific next decision beside each item. If quality records remain with a subcontractor, identify who will request access and whether a controlled viewing arrangement meets the buyer’s need. If a capability is outside the receiving site’s quoted scope, ask whether another provider is proposed. Capture the identity of that provider and the party responsible for reviewing its evidence before committing to a timetable.

FDA (2016) · Quality agreements in contract drug manufacturing

How does an open gap affect supplier selection?

A bidder may return a polished checklist with every box marked complete while attaching evidence for a different facility. Check the legal entity, named address and date on the item that supports the response. Reopen the affected line if the evidence cannot be matched. Record whether the issue prevents the initial file review, affects a later release decision or is simply waiting for confirmation. The buyer can then compare unresolved risks alongside cost and schedule.

ICH / FDA · Q10 Pharmaceutical Quality System

Worked example

If one facility uses the term “accepted” for document receipt while another uses it for quality approval, compare the status definitions in their systems. Ask both owners to identify the equivalent decision in a shared glossary before either site reports the gap as closed.

Prepare your inquiry

Each gap needs a named owner, a specific missing decision and a way to close it.

Select the items you want to ask about.

Certificates of analysis

For a transferred lyophilized powder project, compare the issuing site, lot identifier and certificate version with the agreed first-lot release record.

Read a COA